WeVote

Bill

Bill

HB 487

Appropriations, supplemental appropriations from the Opioid Treatment and Abatement Fund for the fiscal year ending September 30, 2026

2026 Regular Session Introduced by Rex Reynolds

HB 487 appropriates additional opioid settlement funds for Alabama treatment and prevention programs in fiscal 2026 through supplemental budgeting.

Enacted
0
WeVote Research Nonpartisan
Bill Summary · HB 487

Legislative bill overview

HB 487 allocates supplemental funding from Alabama's Opioid Treatment and Abatement Fund for fiscal year 2026. The bill authorizes additional expenditures beyond the regular budget for opioid-related prevention, treatment, and abatement programs. This represents a mid-year budgetary adjustment to address opioid crisis priorities.

Why is this important

Alabama, like most states, receives settlement funds from pharmaceutical companies and distributors related to opioid litigation; this bill determines how those specifically-designated funds are spent. The allocation directly affects treatment capacity, prevention programs, and harm reduction services available to Alabamians struggling with opioid addiction. Supplemental appropriations can indicate either emerging treatment needs or reallocation of previously underspent settlement money.

Potential points of contention

  • Lack of public detail: The bill's specific dollar amounts and program allocations are not visible in the summary provided, making it difficult to assess whether funds match stated priorities
  • Settlement fund usage: Questions may arise about whether these funds are being deployed effectively versus accumulating, and whether they complement or replace traditional state budget allocations for addiction services
  • Accountability mechanisms: Whether the bill includes performance metrics, reporting requirements, or oversight provisions to track how opioid abatement funds are actually utilized

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.